These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2476522)

  • 1. Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.
    Katoch VM; Katoch K; Ramanathan U; Sharma VD; Shivannavar CT; Datta AK; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):615-21. PubMed ID: 2476522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro methods for determination of viability of mycobacteria: comparison of ATP content, morphological index and FDA-EB fluorescent staining in Mycobacterium leprae.
    Katoch VM; Katoch K; Ramu G; Sharma VD; Datta AK; Shivannavar CT; Desikan KV
    Lepr Rev; 1988 Jun; 59(2):137-43. PubMed ID: 2469924
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the viability of Mycobacterium leprae by the fluorescein diacetate/ethidium bromide staining technique.
    Palomino JC; Falconi E; Marin D; Guerra H
    Indian J Lepr; 1991; 63(2):203-8. PubMed ID: 1723741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staining tissue-derived Mycobacterium leprae with fluorescein diacetate and ethidium bromide.
    Kvach JT; Munguia G; Strand SH
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):176-82. PubMed ID: 6202650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
    Wabitsch KR; Meyers WM
    Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
    [No Abstract]   [Full Text] [Related]  

  • 7. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
    Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
    Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of neither green nor red NGR bacilli in FDA-EB staining.
    Bhatia VN; Nirmaladevi B
    Indian J Lepr; 1991; 63(2):218-22. PubMed ID: 1723742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability of Mycobacterium leprae: a comparison of morphological index and fluorescent staining techniques in slit-skin smears and M. leprae suspensions.
    Odinsen O; Nilson T; Humber DP
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):403-8. PubMed ID: 2427626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of radiometric macrophage assay and fluorescein diacetate/ethidium bromide staining for evaluation of M. leprae viability.
    Harshan KV; Prasad HK; Chopra NK; Mishra RS; Gogiya P; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):316-21. PubMed ID: 2439621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
    Naik SS; Bhanage ND; Sawant KV; Ganapati R
    Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
    Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline in lepromatous leprosy.
    Fajardo TT; Villahermosa LG; dela Cruz EC; Abalos RM; Franzblau SG; Walsh GP
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):8-17. PubMed ID: 7730723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacteria in nerve trunks of long-term treated leprosy patients.
    Pereira JH; Palande DD; Gschmeissner SE
    Lepr Rev; 1991 Jun; 62(2):134-42. PubMed ID: 1870375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.
    Grosset JH; Ji BH; Guelpa-Lauras CC; Perani EG; N'Deli LN
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):281-95. PubMed ID: 2198315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.